Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting
NORWOOD, Mass., Sept. 27, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company, today announced that an abstract highlighting pre-clinical data on its CRB-601...
Source: marketscreener.com